Basking Ridge, NJ, United States of America

Kevin D McCormick

This inventor holds 43 USPTO granted patents and 5 published patent applications and 7 EPO patents, primarily in Adrenergic Receptor Modulators. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Schering-Plough Corporation. Active years: 1997-2018.

USPTO Granted Patents = 43 (Patent Applications = 5)

% Patents Active = 37.2

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 6.8

ph-index = 12

Forward Citations = 496(Granted Patents)

Location History:

Edison, NJ (US) (1997 - 2007)
Basking Ridge, NJ (US) (2007 - 2018)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

3 out of 28

Schering-Plough Corporation

patents

4. 2 out of 52

Pharmacopeia Drug Discovery, Inc.

where one patent can have more than one assignee

Years Active: 1997-2018

Loading Chart...

Areas of Expertise:

Alpha2C Agonists

Histamine H3 Antagonists

Neurokinin Antagonists

Biaryl Compounds

Piperidine Compounds

Piperazino Derivatives

Amino Derivatives

Glucocorticoid Agonists

Substituted Anilines

Indole Derivatives

Chromans

Imidazoles

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10138212 - [object Object] (2018-11-27),

2. 9469615 - [object Object] (2016-10-18),

3. 9290453 - [object Object] (2016-03-22),

4. 8927559 - [object Object] (2015-01-06),

5. 8592383 - [object Object] (2013-11-26),

6. 8569312 - Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators (2013-10-29),

7. 8524697 - C20-C21 substituted glucocorticoid receptor agonists (2013-09-03),

8. 8501747 - Functionally selective alpha2C adrenoreceptor agonists (2013-08-06),

9. 8476274 - Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators (2013-07-02),

10. 8470863 - Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists (2013-06-25),

11. 8383818 - Functionally selective alpha2C adrenoreceptor agonists (2013-02-26),

12. 8324213 - Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators (2012-12-04),

13. 8017642 - Functionally selective ALPHA2C adrenoreceptor agonists (2011-09-13),

14. 8003624 - Functionally selective ALPHA2C adrenoreceptor agonists (2011-08-23),

15. 7985748 - ALPHA2C adrenoreceptor agonists (2011-07-26),

Title: The Innovative Journey of Kevin D McCormick

Introduction: Kevin D McCormick, a talented inventor hailing from Basking Ridge, NJ (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: McCormick's latest patents showcase his ingenuity and forward-thinking approach to innovation, with a focus on cutting-edge technologies in the digital space and sustainable energy solutions.

Career Highlights: Throughout his illustrious career, Kevin D McCormick has demonstrated a keen ability to transform ideas into tangible inventions that have the potential to shape the future. His dedication to pushing the boundaries of innovation has earned him recognition as a trailblazer in the industry.

Collaborations: McCormick has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in driving forward his vision for a more technologically advanced and sustainable world.

Conclusion: Kevin D McCormick's passion for innovation, coupled with his relentless drive to create meaningful change, sets him apart as a visionary inventor whose impact will be felt for years to come.